Effect of Fatty Acid Diesters on Permeation of Anti-Inflammatory Drugs Through Rat Skin

REFERENCES

• Guy R.H., Hadgraft J. Structure–Activity Correlations in Percutaneous Absorption. Percutaneous Absorption, 2nd Ed., R.L. Bronaugh, H.I. Maibach. Marcel Dekker, New York 1989; 95–109
   Google Scholar
• Pharmaceutical Skin Penetration Enhancement, K.A. Walters, J. Hadgraft. Marcel Dekker, New York 1993
   Google Scholar
• Sage B.H. Iontophoresis. Percutaneous Penetration Enhancers, E.W. Smith, H.I. Maibach. CRC Press, Boca Raton, FL 1995; 351–368
   Google Scholar
• Percutaneous Penetration Enhancers, E.W. Smith, H.I. Maibach. CRC Press, Boca Raton, FL 1995
   Google Scholar
• Mitragotri S. Synergistic Effect of Enhancers for Transdermal Drug Delivery. Pharm. Res. 2000; 17: 1354–1359
   PubMed Web of Science ®Google Scholar
• Bose S., Ravis W.R., Lin Y., Zhang L., Hofmann G.A., Banga A.K. Electrically-Assisted Transdermal Delivery of Buprenorphine. J. Contr. Rel. 2001; 73: 197–203
   PubMed Web of Science ®Google Scholar
• Ozawa Y., Yamahira T., Sunada H., Nadai T. Influence of Fatty Acid–Alcohol Esters on Percutaneous Absorption of Hydrocortisone Butyrate Propionate. Chem. Pharm. Bull. 1988; 36: 2145–2151
   PubMed Web of Science ®Google Scholar
• Sato K., Sugibayashi K., Morimoto Y. Effect and Mode of Action of Aliphatic Esters on the In Vitro Skin Permeation of Nicorandil. Int. J. Pharm. 1988; 43: 31–40
   Web of Science ®Google Scholar
• Kumar S., Malick A.W., Meltzer N.M., Mouskountakis J.D., Behl C.R. Studies of In Vitro Skin Permeation and Retention of a Leukotriene Antagonist from Topical Vehicles with a Hairless Guinea Pig Model. J. Pharm. Sci. 1992; 81: 631–634
   PubMed Web of Science ®Google Scholar
• Harada S., Takahashi Y., Nakagawa H. Transdermal Administration of Emedastine. Biol. Pharm. Bull. 1993; 16: 884–888
   PubMed Web of Science ®Google Scholar
• Fujii M., Hori N., Shiozawa K., Wakabayashi K., Kawhara M., Matsumoto M. Effect of Fatty Acid Esters on Permeation of Ketoprofen Through Hairless Rat Skin. Int. J. Pharm. 2000; 205: 117–125
   PubMed Web of Science ®Google Scholar
• Takahashi K., Suzuki T., Sakano H., Mizuno N. Effect of Vehicles on Diclofenac Permeation Across Excised Rat Skin. Biol. Pharm. Bull. 1995; 18: 571–575
   PubMed Web of Science ®Google Scholar
• Potts R.O., Francoeur M.L. Infrared Spectroscopy of Stratum Corneum Lipids: In Vitro Results and Their Relevance to Permeability. Pharmaceutical Skin Permeation Enhancement, K.A. Walters, J. Hadgraft. Marcel Dekker, New York 1993; 269–291
   Google Scholar
• Naik A., Guy R.H. Infrared Spectroscopic and Differential Scanning Calorimetric Investigations of the Stratum Corneum Barrier Function. Mechanisms of Transdermal Drug Delivery, R.O. Potts, R.H. Guy. Marcel Dekker, New York 1997; 87–162
   Google Scholar
• Bommannan D.B., Pott R.O., Guy R.H. Examination of the Effect of Ethanol on Human Corneum In Vivo Using Infrared Spectroscopy. J. Contr. Rel. 1991; 16: 299–304
   Web of Science ®Google Scholar
• Yamana T., Tsuji A., Miyamoto E., Kubo O. Novel Method for Determination of Partition Coefficients of Penicillins and Cephalosporins by High-Pressure Liquid Chromatography. J. Pharm. Sci. 1977; 66: 747–749
   PubMed Web of Science ®Google Scholar
• Okamoto H., Muta K., Hashida M., Sezaki H. Percutaneous Penetration of Acyclovir Through Excised Hairless Mouse and Rat Skin: Effect of Vehicle and Percutaneous Enhancer. Pharm. Res. 1990; 7: 64–68
   PubMed Web of Science ®Google Scholar
• Philips C.A., Michniak B.B. Transdermal Delivery of Drugs with Differing Lipophilicities Using Azone Analogs as Dermal Penetration Enhancers. J. Pharm. Sci. 1995; 84: 1427–1433
   PubMed Web of Science ®Google Scholar
• Borras-Blasco J., Lopez A., Morant M., Diez-Sales O., Herraez-Dominguez M. Influence of Sodium Lauryl Sulfate on In Vitro Percutaneous Absorption of Compounds with Different Lipophilicity. Eur. J. Pharm. Sci. 1997; 5: 15–22
   Web of Science ®Google Scholar
• Godwin D.A., Michniak B.B. Influence of Drug Lipophilicity on Terpenes as Transdermal Penetration Enhancers. Drug Dev. Ind. Pharm. 1999; 25: 905–915
   PubMed Web of Science ®Google Scholar
• Sung K.C., Fang J., Yoa-Pu Hu O. Delivery of Nalbuphine and Its Prodrugs Across Skin by Passive Diffusion and Iontophoresis. J. Contr. Rel. 2000; 67: 1–8
   PubMed Web of Science ®Google Scholar
• El-Kattan A.F., Asbill C.S., Michniak B.B. The Effect of Terpene Enhancer Lipophilicity on the Percutaneous Permeation of Hydrocortisone Formulated in HPMC Gel Systems. Int. J. Pharm. 2000; 198: 179–189
   PubMed Web of Science ®Google Scholar
• El-Kattan A.F., Asbill C.S., Kim N., Michniak B.B. The Effects of Terpene Enhancers on the Percutaneous Permeation of Drugs with Different Lipophilicities. Int. J. Pharm. 2001; 215: 229–240
   PubMed Web of Science ®Google Scholar
• Lee C.K., Uchida T., Kitagawa K., Yagi A., Kim N.-S., Goto S. Skin Permeability of Various Drugs with Different Lipophilicity. J. Pharm. Sci. 1994; 83: 562–565
   PubMed Web of Science ®Google Scholar
• Williams A., Barry B. Terpenes and the Lipid–Protein-Partitioning Theory of Skin Penetration Enhancement. Pharm. Res. 1991; 8: 17–24
   PubMed Web of Science ®Google Scholar
• Bouwstra J.A., Bodde H. Human SC Barrier Impairment by N-Alkyl-azacycloheptanones: A Mechanistic Study of Drug Flux Enhancement, Azone Mobility, and Protein and Lipid Perturbation. Percutaneous Penetration Enhancers, E.W. Smith, H.I. Maibach. CRC Press, Boca Raton, FL 1995; 137–157
   Google Scholar
• Aungst B.J. Fatty Acids as Skin Permeation Enhancers. Percutaneous Penetration Enhancers, E.W. Smith, H.I. Maibach. CRC Press, Boca Raton, FL 1995; 277–287
   Google Scholar
• Golden G.M., Guzek D.B., Kennedy A.H., Mckie J.E., Potts R.O. Stratum Corneum Lipid Phase Transitions and Water Barrier Properties. Biochemistry 1987; 26: 2382–2388
   PubMed Web of Science ®Google Scholar
• Golden G.M., Mckie J.E., Potts R.O. Role of Stratum Corneum Lipid Fluidity in Transdermal Drug Flux. J. Pharm. Sci. 1987; 76: 25–28
   PubMed Web of Science ®Google Scholar
• Knutson K., Potts R.O., Guzek D.B., Golden G.M., Mckie J.E., Lambert W.J., Higuchi W.I. Macro- and Molecular Physical–Chemical Considerations in Understanding Drug Transport in the Stratum Corneum. J. Contr. Rel. 1985; 2: 67–87
   Google Scholar
• Knutson K., Krill S.L., Lambert W.J., Higuchi W.I. Physicochemical Aspects of Transdermal Permeation. J. Contr. Rel. 1987; 6: 59–74
   Google Scholar
• Casal H.L., Mantsch H.H. Polymeric Phase Behavior of Phospholipid Membranes Studied by Infrared Spectroscopy. Biochim. Biophys. Acta 1984; 779: 381–401
   PubMed Web of Science ®Google Scholar
• Goates C.Y., Knutson K. Enhanced Permeation of Polar Compounds Through Human Epidermis. I. Permeability and Membrane Structural Change in the Presence of Short-Chain Alcohols. Biochim. Biophys. Acta 1994; 1195: 169–179
   PubMed Web of Science ®Google Scholar
• Zhao K., Singh J. In Vitro Percutaneous Absorption Enhancement of Propranolol Hydrochloride Through Porcine Epidermis by Terpenes/Ethanol. J. Contr. Rel. 1999; 62: 359–366
   PubMed Web of Science ®Google Scholar
• Sorasuchart W., Wardrop J., Ayres J.W. Drug Release from Spray Layered and Coated Drug-Containing Beads: Effects of pH and Comparison of Different Dissolution Methods. Drug Dev. Ind. Pharm. 1999; 25: 1093–1098
   PubMed Web of Science ®Google Scholar
• Cantabrana B., Perez Vallina J.R., Menendez L., Hidalgo A. Spasmolytic and Calmodulin Inhibitory Effect of Non-steroidal Anti-inflammatory Drugs In Vitro. Life Sci. 1995; 57: 1333–1341
   PubMed Web of Science ®Google Scholar
• Newton D.W., Kluza R.B. pKa Values of Medicinal Compounds in Pharmacy Practice. Drug Intell. Clin. Pharm. 1978; 12: 546–554
   Google Scholar